Table 4.
n (%) | |
---|---|
Reason for continuation (n = 43) | |
Not addressed | 20 (46.5) |
Active treatment still indicated | 15 (34.9) |
Patient/family preference | 6 (14.0) |
Palliative | 6 (14.0) |
Prophylaxis still indicated | 8 (18.6) |
Benefit outweighs risk | 1 (3.0) |
Reason for De-escalation (n = 17) | |
Not addressed | 2 (11.8) |
Bleeding risk | 10 (58.8) |
Patient/family preference | 4 (23.5) |
No indication for prior anticoagulation | 3 (17.6) |
New contraindication | 2 (11.8) |
More consistent with palliative goals of care | 5 (29.4) |
Ease of monitoring | 1 (5.9) |
Percentages do not sum to 100% because prescribers may have documented more than reason for continuation or de-escalation.